These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 32717689

  • 1. Design, synthesis ADMET and molecular docking of new imidazo[4,5-b]pyridine-5-thione derivatives as potential tyrosyl-tRNA synthetase inhibitors.
    Othman IMM, Gad-Elkareem MAM, Hassane Anouar E, Aouadi K, Kadri A, Snoussi M.
    Bioorg Chem; 2020 Sep; 102():104105. PubMed ID: 32717689
    [Abstract] [Full Text] [Related]

  • 2. Adenosine analogs as inhibitors of tyrosyl-tRNA synthetase: Design, synthesis and antibacterial evaluation.
    Wei W, Shi WK, Wang PF, Zeng XT, Li P, Zhang JR, Li Q, Tang ZP, Peng J, Wu LZ, Xie MQ, Liu C, Li XH, Wang YC, Xiao ZP, Zhu HL.
    Bioorg Med Chem; 2015 Oct 15; 23(20):6602-11. PubMed ID: 26404408
    [Abstract] [Full Text] [Related]

  • 3. New polyfunctional imidazo[4,5-C]pyridine motifs: synthesis, crystal studies, docking studies and antimicrobial evaluation.
    Jose G, Suresha Kumara TH, Nagendrappa G, Sowmya HB, Jasinski JP, Millikan SP, Chandrika N, More SS, Harish BG.
    Eur J Med Chem; 2014 Apr 22; 77():288-97. PubMed ID: 24657565
    [Abstract] [Full Text] [Related]

  • 4. Tyrosyl-tRNA synthetase inhibitors as antibacterial agents: synthesis, molecular docking and structure-activity relationship analysis of 3-aryl-4-arylaminofuran-2(5H)-ones.
    Xiao ZP, Ma TW, Liao ML, Feng YT, Peng XC, Li JL, Li ZP, Wu Y, Luo Q, Deng Y, Liang X, Zhu HL.
    Eur J Med Chem; 2011 Oct 22; 46(10):4904-14. PubMed ID: 21856050
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Design, synthesis, structure elucidation, antimicrobial, molecular docking, and SAR studies of novel urea derivatives bearing tricyclic aromatic hydrocarbon rings.
    Sroor FM, El-Sayed AF, Abdelraof M.
    Arch Pharm (Weinheim); 2024 Jun 22; 357(6):e2300738. PubMed ID: 38466125
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In silico Identification of Potential Inhibitors against Staphylococcus aureus Tyrosyl-tRNA Synthetase.
    Monobe K, Taniguchi H, Aoki S.
    Curr Comput Aided Drug Des; 2024 Jun 22; 20(5):452-462. PubMed ID: 37309761
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synthesis, biological evaluation and molecular docking studies of novel quinazolinones as antitubercular and antimicrobial agents.
    Kumar Pandey S, Yadava U, Upadhyay A, Sharma ML.
    Bioorg Chem; 2021 Mar 22; 108():104611. PubMed ID: 33484939
    [Abstract] [Full Text] [Related]

  • 17. Synthesis, structure elucidation, Hirshfeld surface analysis, DFT, and molecular docking of new 6-bromo-imidazo[4,5-b]pyridine derivatives as potential tyrosyl-tRNA synthetase inhibitors.
    Jabri Z, Thiruvalluvar AA, Sghyar R, Mague JT, Sabir S, Rodi YK, Anouar EH, Misbahi K, Sebbar NK, Essassi EM.
    J Biomol Struct Dyn; 2023 Mar 22; 41(21):12347-12362. PubMed ID: 36744539
    [Abstract] [Full Text] [Related]

  • 18. Rational design, molecular docking and synthesis of novel homopiperazine linked imidazo[1,2-a]pyrimidine derivatives as potent cytotoxic and antimicrobial agents.
    Mantipally M, Gangireddy MR, Gundla R, Badavath VN, Mandha SR, Maddipati VC.
    Bioorg Med Chem Lett; 2019 Aug 15; 29(16):2248-2253. PubMed ID: 31239178
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and evaluation of new tyrosyl-tRNA synthetase inhibitors as antibacterial agents based on a N2-(arylacetyl)glycinanilide scaffold.
    Xiao ZP, Wei W, Wang PF, Shi WK, Zhu N, Xie MQ, Sun YW, Li LX, Xie YX, Zhu LS, Tang N, Ouyang H, Li XH, Wang GC, Zhu HL.
    Eur J Med Chem; 2015 Sep 18; 102():631-8. PubMed ID: 26318069
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.